Chemistree Investee Immunoflex Completes Clinical Study And Submits Us And International Patent Applications
Vancouver, British Columbia, July 13th, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company Immunoflex Therapeutics Inc. (“ImmunoFlex”™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The exploratory trial was the
July 13, 2021
No Comments